{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:30:24Z","timestamp":1788820224446,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.euroneuro.2015.07.024","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T06:40:43Z","timestamp":1439016043000},"page":"1960-1967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep \u2013 A randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"25","author":[{"given":"Siegfried","family":"Kasper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion","family":"Anghelescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Dienel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.07.024_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib2","doi-asserted-by":"crossref","unstructured":"Baldinger, P., Hoflich, A.S., Mitterhauser, M., Hahn, A., Rami-Mark, C., Spies, M., Wadsak, W., Lanzenberger, R., Kasper, S., 2014. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging, Int. J. Neuropsychopharmacol. 31, 18(4). pii: pyu063. 10.1093\/ijnp\/pyu063","DOI":"10.1093\/ijnp\/pyu063"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1092852900025815","article-title":"Defining response and remission in anxiety disorders: toward an integrated approach","volume":"11","author":"Bandelow","year":"2006","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2307\/2533441","article-title":"Evaluation of experiments with adaptive interim analyses","volume":"50","author":"Bauer","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib6","series-title":"British Herbal Pharmacopoeia","author":"British Herbal Medicine Association","year":"1996"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib7","unstructured":"Bundesgesundheitsamt, 1984. Monographie \u2013 Lavandulae flos (Lavendelbl\u00fcten). Bundesanzeiger 228 (05.12.84)."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib9","series-title":"Lavender (Lavandula spp.)","author":"Chu","year":"2001"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib10","series-title":"Guideline on Adjustment for Baseline Covariates \u2013 Draft. CPMP\/EWP\/558\/95 rev 2","author":"Committee for Medicinal Products for Human Use","year":"2013"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib11","first-page":"193","article-title":"Hamilton Anxiety Scale (HAMA)","author":"Hamilton","year":"1976"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib12","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1211\/jpp.60.11.0013","article-title":"Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels","volume":"60","author":"Huang","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2015.07.024_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/13651501.2013.813555","article-title":"An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review","volume":"17","author":"Kasper","year":"2013","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1017\/S1461145714000017","article-title":"Lavender oil preparation Silexan is effective in generalized anxiety disorder \u2013 a randomized, double-blind comparison to placebo and paroxetine","volume":"17","author":"Kasper","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10354-010-0845-7","article-title":"Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder \u2013 evidence from clinical trials","volume":"160","author":"Kasper","year":"2010","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/YIC.0b013e32833b3242","article-title":"Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of \u2018subsyndromal\u2019 anxiety disorder: a randomized, double-blind, placebo controlled trial","volume":"25","author":"Kasper","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/NMD.0b013e3181c29992","article-title":"Differentiating generalized anxiety disorder from anxiety disorder not otherwise specified","volume":"197","author":"Lawrence","year":"2009","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2015.07.024_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2307\/2532142","article-title":"Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate","volume":"47","author":"Lehmacher","year":"1991","journal-title":"Biometrics"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib19","first-page":"217","article-title":"12 \u2013 CGI. Clinical Global Impressions","author":"National Institute of Mental Health","year":"1970"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2307\/2531158","article-title":"Procedures for comparing samples with multiple endpoints","volume":"40","author":"O\u2019Brien","year":"1984","journal-title":"Biometrics"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1037\/a0026517","article-title":"Human anterior and posterior hippocampus respond distinctly to state and trait anxiety","volume":"12","author":"Satpute","year":"2012","journal-title":"Emotion"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib22","doi-asserted-by":"crossref","first-page":"e59998","DOI":"10.1371\/journal.pone.0059998","article-title":"Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels","volume":"8","author":"Schuwald","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib23","first-page":"162","article-title":"Subsyndromale Angstst\u00f6rungen: definition, messparameter, epidemiologie","volume":"12","author":"Volz","year":"2011","journal-title":"J. Neurol. Neuropsychiatr. Psychiatr."},{"issue":"Suppl. 8","key":"10.1016\/j.euroneuro.2015.07.024_bib24","first-page":"24","article-title":"Generalized anxiety and depression in primary care: prevalence, recognition, and management","volume":"63","author":"Wittchen","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib25","series-title":"International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.euroneuro.2015.07.024_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0033-3182(71)71479-0","article-title":"A rating instrument for anxiety disorders","volume":"12","author":"Zung","year":"1971","journal-title":"Psychosomatics"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15002424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15002424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T01:17:08Z","timestamp":1567041428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15002424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0924977X15002424"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.07.024","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep \u2013 A randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}